ClariVest Asset Management’s Allergan plc AGN Stock Holding History

ClariVest Asset Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,551	Closed	-$357K	–	753
2016 Q3	$357K	Hold	1,551	–	–	0.01%	424
2016 Q2	$359K	Sell	1,551 -39,015	-96%	-$9M	0.01%	402
2016 Q1	$10.9M	Sell	40,566 -25,123	-38%	-$7.19M	0.33%	78
2015 Q4	$20.5M	Sell	65,689 -96,598	-60%	-$28.8M	0.58%	60
2015 Q3	$44.1M	Buy	162,287 +11,969	+8%	+$3.68M	1.33%	22
2015 Q2	$45.6M	Hold	150,318	–	–	1.36%	17
2015 Q1	$44.7M	Buy	150,318 +8,425	+6%	+$2.4M	1.37%	17
2014 Q4	$36.5M	Buy	141,893 +3,888	+3%	+$972K	1.29%	22
2014 Q3	$33.3M	Sell	138,005 -19	-0%	-$4.25K	1.22%	20
2014 Q2	$30.8M	Sell	138,024 -70,317	-34%	-$14.6M	1.16%	24
2014 Q1	$42.9M	Buy	+208,341	New	+$41.3M	1.74%	9
2013 Q4	–	Sell	-189,280	Closed	-$27.3M	–	670
2013 Q3	$27.3M	Sell	189,280 -24,862	-12%	-$3.31M	1.24%	19
2013 Q2	$27M	Buy	+214,142	New	+$24.2M	1.21%	17

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClariVest Asset Management's AGN Position: Q4 2016 in Review

ClariVest Asset Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 1,551 shares — an estimated $357K sold.

ClariVest Asset Management first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $45.6M in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

ClariVest Asset Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
ClariVest Asset Management sold 1,551 Allergan plc shares in Q4 2016, an estimated $357K.
ClariVest Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
ClariVest Asset Management's Allergan plc position peaked at $45.6M in Q2 2015.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on ClariVest Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.